Literature DB >> 9176119

Sequence, specificity and crystallization of an oestrone-3-glucuronide antibody (3910).

M He1, M Gani, O Livnah, E A Stura, D Beale, J Coley, I A Wilson, M J Taussig.   

Abstract

We describe the specificity profile and V region sequences of a high-affinity monoclonal antibody (mAb), 3910, directed against oestrone-3-glucuronide (E3G). Inhibition studies show that the D-ring is critical for steroid specificity, while the glucuronic acid attached to the A ring is required for high binding affinity, suggesting that both 'ends' of the E3G ligand are recognized. The VH domain is encoded by a gene from the VH7183 family, while VL appears to be encoded by the Vk5.1 gene (kappa II subgroup) with a deletion of six residues from complementarity-determining region-1 (CDR1). The VH CDR3 is 10 amino acid residues in length, of which D/N contributes five residues. Comparison of VH CDR of 3910 with those of mAb against progesterone (DB3) and digoxin (26-10, 40-50), for which crystal structures have been determined, suggests that aromatic side chains are important for E3G binding and that tyrosine residues H50, H97 and H100 may interact with the ligand. The Fab fragment of 3910 has been crystallized in its native and steroid (E3G and oestriol-3-glucuronide) complexed forms. An X-ray diffraction data set to 3 A resolution has been collected for the native Fab.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176119      PMCID: PMC1456692          DOI: 10.1046/j.1365-2567.1997.00099.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

Review 1.  Conformations of immunoglobulin hypervariable regions.

Authors:  C Chothia; A M Lesk; A Tramontano; M Levitt; S J Smith-Gill; G Air; S Sheriff; E A Padlan; D Davies; W R Tulip
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

Review 2.  Immunochemical tests of potential fertility.

Authors:  W P Collins
Journal:  Biochem Soc Trans       Date:  1992-02       Impact factor: 5.407

3.  Monoclonal BALB/c anti-progesterone antibodies use family IX variable region heavy chain genes.

Authors:  E Deverson; C Berek; M Taussig; A Feinstein
Journal:  Eur J Immunol       Date:  1987-01       Impact factor: 5.532

4.  Two V kappa germ-line genes related to the GAT idiotypic network (Ab1 and Ab3/Ab1') account for the major subfamilies of the mouse V kappa-1 variability subgroup.

Authors:  S Corbet; M Milili; M Fougereau; C Schiff
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

5.  Optimization of primer sequences for mouse scFv repertoire display library construction.

Authors:  H Zhou; R J Fisher; T S Papas
Journal:  Nucleic Acids Res       Date:  1994-03-11       Impact factor: 16.971

6.  Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex.

Authors:  J H Arevalo; E A Stura; M J Taussig; I A Wilson
Journal:  J Mol Biol       Date:  1993-05-05       Impact factor: 5.469

7.  Molecular basis of crossreactivity and the limits of antibody-antigen complementarity.

Authors:  J H Arevalo; M J Taussig; I A Wilson
Journal:  Nature       Date:  1993-10-28       Impact factor: 49.962

8.  Blot-sequencing of antibodies: application to analysis of V gene usage among anti-steroid monoclonal antibodies.

Authors:  M J Taussig; P R Symington; M Woods; M J Sims; D Beale; A S Humphreys; A J Northrop; P J Barker; N S Huskisson; J Coley
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

9.  Preliminary crystallographic investigations of glycinamide ribonucleotide transformylase.

Authors:  E A Stura; D L Johnson; J Inglese; J M Smith; S J Benkovic; I A Wilson
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

10.  Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response.

Authors:  N S Levy; U V Malipiero; S G Lebecque; P J Gearhart
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Molecular mechanisms of FIV infection.

Authors:  John H Elder; Magnus Sundstrom; Sohela de Rozieres; Aymeric de Parseval; Chris K Grant; Ying-Chuan Lin
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.